11-2527950-C-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_000218.3(KCNQ1):c.409C>T(p.Leu137Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L137P) has been classified as Uncertain significance.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNQ1 | NM_000218.3 | c.409C>T | p.Leu137Phe | missense_variant | Exon 2 of 16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNQ1 | ENST00000155840.12 | c.409C>T | p.Leu137Phe | missense_variant | Exon 2 of 16 | 1 | NM_000218.3 | ENSP00000155840.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251426 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461794Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727206 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:1
p.Leu137Phe (CTC>TTC): c.409 C>T in exon 2 of the KCNQ1 gene (NM_000218.2). The L137F mutation in the KCNQ1 gene has been previously reported in association with LQTS and Jervell and Lange-Nielsen (JLN) syndrome (Napolitano et al., 2005; Guda P et al., 2007). L137F was identified as a novel mutation and was absent from 800 control chromosomes (Napolitano et al., 2005). Furthermore, the L137F mutation was not observed inapproximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Although L137F results in a conservative amino acid substitution of one non-polar amino acid for another, the L137 residue is conserved across species. This residue is predicted to be buried in the S1 transmembrane segment of the voltage sensing domain of the KVLQT1 channel, and alteration of this spatially constrained residue is predicted to result in destabilization of the transmembrane alpha-helix (Jackson and Accili, 2008; Oberai A et al. 2009). Other mutations in nearby residues (V133I, L134P, C136F, T144A, E146K) have been reported in association with LQTS, further supporting the functional importance of this residue and region of the protein. In summary, L137F in the KCNQ1 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s). -
Long QT syndrome Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 137 of the KCNQ1 protein (p.Leu137Phe). This variant is present in population databases (rs199473450, gnomAD 0.003%). This missense change has been observed in individual(s) with longQT syndrome (PMID: 16414944, 34505893). ClinVar contains an entry for this variant (Variation ID: 53042). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNQ1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:16414944). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at